Serina Therapeutics Appoints New CMO, Director
Ticker: SER · Form: 8-K · Filed: Jul 12, 2024 · CIK: 1708599
| Field | Detail |
|---|---|
| Company | Serina Therapeutics, Inc. (SER) |
| Form Type | 8-K |
| Filed Date | Jul 12, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $1,000, $0.06 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment, personnel
TL;DR
Serina Therapeutics brings in a new CMO and board member, watch for strategic changes.
AI Summary
Serina Therapeutics, Inc. announced on July 9, 2024, the appointment of Dr. David E. Johnson as Chief Medical Officer and the election of Ms. Jennifer L. Johnson to its Board of Directors. The company also disclosed compensatory arrangements for these individuals. Serina Therapeutics, formerly AgeX Therapeutics, Inc., is based in Huntsville, Alabama.
Why It Matters
The appointment of a new Chief Medical Officer and a board member can signal strategic shifts or new directions for the company's medical and governance strategies.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can indicate significant strategic shifts or internal challenges, requiring closer monitoring.
Key Numbers
- 0001708599 — Central Index Key (Unique identifier for Serina Therapeutics, Inc.)
- 001-38519 — SEC File Number (SEC filing number for Serina Therapeutics, Inc.)
Key Players & Entities
- Serina Therapeutics, Inc. (company) — Registrant
- Dr. David E. Johnson (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. Johnson (person) — Elected to Board of Directors
- AgeX Therapeutics, Inc. (company) — Former Company Name
- July 9, 2024 (date) — Date of earliest event reported
- Huntsville, Alabama (location) — Principal executive offices
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. David E. Johnson has been appointed as the new Chief Medical Officer.
Who has been elected to the Board of Directors?
Ms. Jennifer L. Johnson has been elected to the Board of Directors.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is July 9, 2024.
What was Serina Therapeutics, Inc.'s former company name?
Serina Therapeutics, Inc.'s former company name was AgeX Therapeutics, Inc.
Where are Serina Therapeutics, Inc.'s principal executive offices located?
Serina Therapeutics, Inc.'s principal executive offices are located at 601 Genome Way, Suite 2001, Huntsville, Alabama 35806.
Filing Stats: 586 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-07-12 16:52:49
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SER NYSE American Indic
- $1,000 — e salary and additional compensation of $1,000 per month for a period of twelve months
- $0.06 — 's Common Stock at an exercise price of $0.06 per share, pursuant to certain Nonquali
Filing Documents
- form8-k.htm (8-K) — 34KB
- 0001493152-24-027113.txt ( ) — 205KB
- ser-20240709.xsd (EX-101.SCH) — 3KB
- ser-20240709_lab.xml (EX-101.LAB) — 33KB
- ser-20240709_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SERINA THERAPEUTICS, INC. Date: July 12, 2024 By: /s/ Steven Ledger Interim Chief Executive Officer